EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms

被引:63
|
作者
van Lengerich, Bettina [1 ]
Agnew, Christopher [1 ]
Puchner, Elias M. [2 ]
Huang, Bo [3 ,4 ]
Jura, Natalia [1 ,5 ]
机构
[1] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA
[2] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA
[3] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA
[5] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA
基金
美国国家卫生研究院;
关键词
HER/ERBB receptors; receptor tyrosine kinase signaling; receptor clustering; STORM; EGFR activation; EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; HIGHER-ORDER OLIGOMERS; CELL-SURFACE; LIVING CELLS; NANOCLUSTER FORMATION; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; ERBB RECEPTORS; LUNG-CANCER;
D O I
10.1073/pnas.1617994114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Heteromeric interactions between the catalytically impaired human epidermal growth factor receptor (HER3/ERBB3) and its catalytically active homologs EGFR and HER2 are essential for their signaling. Different ligands can activate these receptor pairs but lead to divergent signaling outcomes through mechanisms that remain largely unknown. We used stochastic optical reconstruction microscopy (STORM) with pair-correlation analysis to show that EGF and neuregulin (NRG) can induce different extents of HER3 clustering that are dependent on the nature of the coexpressed HER receptor. We found that the presence of these clusters correlated with distinct patterns and mechanisms of receptor phosphorylation. NRG induction of HER3 phosphorylation depended on the formation of the asymmetric kinase dimer with EGFR in the absence of detectable higher-order oligomers. Upon EGF stimulation, HER3 paralleled previously observed EGFR behavior and formed large clusters within which HER3 was phosphorylated via a noncanonical mechanism. HER3 phosphorylation by HER2 in the presence of NRG proceeded through still another mechanism and involved the formation of clusters within which receptor phosphorylation depended on asymmetric kinase dimerization. Our results demonstrate that the higher-order organization of HER receptors is an essential feature of their ligand-induced behavior and plays an essential role in lateral cross-activation of the receptors. We also show that HER receptor ligands exert unique effects on signaling by modulating this behavior.
引用
收藏
页码:E2836 / E2845
页数:10
相关论文
共 50 条
  • [21] Clinical impact of HER3/ERBB3 expression in primary and recurrent ovarian cancer
    Yokosu, Kota
    Harano, Kenichi
    Yamashita, Riu
    Fujii, Satoshi
    Tanabe, Hiroshi
    Mukohara, Toru
    Sato, Saori
    Kobayashi, Maki
    Oshima, Keiko
    Kimura, Hiroko
    Takahashi, Hiroyuki
    Saito, Motoaki
    Yamada, Kyosuke
    Takano, Hirokuni
    Okamoto, Aikou
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A290 - A290
  • [22] Molecular modeling and simulation of the HER3/ErbB3 pseudo-kinase domain
    Telesco, Shannon E.
    Liu, Yingting
    Radhakrishnan, Ravi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [23] ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
    Shi, Fumin
    Telesco, Shannon E.
    Liu, Yingting
    Radhakrishnan, Ravi
    Lemmon, Mark A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) : 7692 - 7697
  • [24] ErbB3/HER3和erbB4/HER4在肺癌中的表达
    王治民
    陈少茂
    邓在春
    现代实用医学, 2003, (01) : 12 - 14
  • [25] ErbB3/Her3基因重组慢病毒的构建及应用
    生秀梅
    王正新
    郑州大学学报(医学版), 2016, 51 (05) : 572 - 575
  • [26] Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
    Gaborit, Nadege
    Lindzen, Moshit
    Yarden, Yosef
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) : 576 - 592
  • [27] Effective reduction of PD-L1 expression by simultaneous blockade of EGFR and HER3 (ErbB3) in head and neck cancer
    Chen, Zhuo Georgia
    Wang, Dongsheng
    Griffith, Christopher C.
    Nannapaneni, Sreenivas
    Steuer, Conor
    Patel, Mihir R.
    El-Deiry, Mark W.
    Wang, Xu
    Zhang, Yuzi
    Chen, Zhengjia
    Alvarado, Diego
    Shin, Dong M.
    Saba, Nabil F.
    CANCER RESEARCH, 2018, 78 (13)
  • [28] PHOSPHORYLATION OF THE ERBB3/HER3 GENE-PRODUCT BY THE EPIDERMAL GROWTH-FACTOR RECEPTOR PROTEIN-TYROSINE KINASE
    KOLAND, JG
    KIM, HH
    SIERKE, SL
    FASEB JOURNAL, 1994, 8 (07): : A1228 - A1228
  • [29] ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase
    Biochemical Journal, 1998, 333 (pt 3): : 757 - 763
  • [30] ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase
    Hellyer, NJ
    Cheng, K
    Koland, JG
    BIOCHEMICAL JOURNAL, 1998, 333 : 757 - 763